These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 21917632

  • 1. Iron reduction by deferoxamine leads to amelioration of adiposity via the regulation of oxidative stress and inflammation in obese and type 2 diabetes KKAy mice.
    Tajima S, Ikeda Y, Sawada K, Yamano N, Horinouchi Y, Kihira Y, Ishizawa K, Izawa-Ishizawa Y, Kawazoe K, Tomita S, Minakuchi K, Tsuchiya K, Tamaki T.
    Am J Physiol Endocrinol Metab; 2012 Jan 01; 302(1):E77-86. PubMed ID: 21917632
    [Abstract] [Full Text] [Related]

  • 2. Iron chelation inhibits NF-kappaB-mediated adhesion molecule expression by inhibiting p22(phox) protein expression and NADPH oxidase activity.
    Li L, Frei B.
    Arterioscler Thromb Vasc Biol; 2006 Dec 01; 26(12):2638-43. PubMed ID: 16973969
    [Abstract] [Full Text] [Related]

  • 3. Iron chelation by deferoxamine prevents renal interstitial fibrosis in mice with unilateral ureteral obstruction.
    Ikeda Y, Ozono I, Tajima S, Imao M, Horinouchi Y, Izawa-Ishizawa Y, Kihira Y, Miyamoto L, Ishizawa K, Tsuchiya K, Tamaki T.
    PLoS One; 2014 Dec 01; 9(2):e89355. PubMed ID: 24586712
    [Abstract] [Full Text] [Related]

  • 4. Zn/Ga-DFO iron-chelating complex attenuates the inflammatory process in a mouse model of asthma.
    Bibi H, Vinokur V, Waisman D, Elenberg Y, Landesberg A, Faingersh A, Yadid M, Brod V, Pesin J, Berenshtein E, Eliashar R, Chevion M.
    Redox Biol; 2014 Dec 01; 2():814-9. PubMed ID: 25009783
    [Abstract] [Full Text] [Related]

  • 5. Long term comparative studies in thalassemia patients treated with deferoxamine or a deferoxamine/deferiprone combination. Identification of effective chelation therapy protocols.
    Kolnagou A, Economides C, Eracleous E, Kontoghiorghes GJ.
    Hemoglobin; 2008 Dec 01; 32(1-2):41-7. PubMed ID: 18274982
    [Abstract] [Full Text] [Related]

  • 6. NOX2 deficiency attenuates markers of adiposopathy and brain injury induced by high-fat diet.
    Pepping JK, Freeman LR, Gupta S, Keller JN, Bruce-Keller AJ.
    Am J Physiol Endocrinol Metab; 2013 Feb 15; 304(4):E392-404. PubMed ID: 23233541
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Nanogel-DFO conjugates as a model to investigate pharmacokinetics, biodistribution, and iron chelation in vivo.
    Wang Y, Liu Z, Lin TM, Chanana S, Xiong MP.
    Int J Pharm; 2018 Mar 01; 538(1-2):79-86. PubMed ID: 29341909
    [Abstract] [Full Text] [Related]

  • 12. Kinetics of removal and reappearance of non-transferrin-bound plasma iron with deferoxamine therapy.
    Porter JB, Abeysinghe RD, Marshall L, Hider RC, Singh S.
    Blood; 1996 Jul 15; 88(2):705-13. PubMed ID: 8695819
    [Abstract] [Full Text] [Related]

  • 13. Deferoxamine B but not deferoxamine G1 inhibits cytokine production in murine bone marrow macrophages.
    Autenrieth IB, Bohn E, Ewald JH, Heesemann J.
    J Infect Dis; 1995 Aug 15; 172(2):490-6. PubMed ID: 7622893
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Deferoxamine therapy in high-ferritin diabetes.
    Cutler P.
    Diabetes; 1989 Oct 15; 38(10):1207-10. PubMed ID: 2792574
    [Abstract] [Full Text] [Related]

  • 16. Deletion of p22phox-dependent oxidative stress in the hypothalamus protects against obesity by modulating β3-adrenergic mechanisms.
    Lob HE, Song J, Hurr C, Chung A, Young CN, Mark AL, Davisson RL.
    JCI Insight; 2017 Jan 26; 2(2):e87094. PubMed ID: 28138551
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Uses and limitations of serum ferritin, magnetic resonance imaging T2 and T2* in the diagnosis of iron overload and in the ferrikinetics of normalization of the iron stores in thalassemia using the International Committee on Chelation deferiprone/deferoxamine combination protocol.
    Kolnagou A, Yazman D, Economides C, Eracleous E, Kontoghiorghes GJ.
    Hemoglobin; 2009 Jan 26; 33(5):312-22. PubMed ID: 19814677
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.